التداخل بين روكسوليتينيب والتبغ والتدخين

Secondary Malignancies: Monitor for development of secondary malignancies, particularly in patients who are current or past smokers.

Consider the benefits and risks for the individual patient prior to initiating or continuing therapy with JAKAFI/JAKAFI XR particularly in patients who are current or past smokers and patients with other cardiovascular risk factors.

Patients who are current or past smokers are at additional increased risk.